Operating Expenses - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Operating Expenses Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Operating Expenses
-€21.6m
CAGR 3-Years
-60%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Operating Expenses
-€222m
CAGR 3-Years
-11%
CAGR 5-Years
-29%
CAGR 10-Years
-17%
Nanobiotix SA
PAR:NANO
Operating Expenses
-€56.8m
CAGR 3-Years
-16%
CAGR 5-Years
-13%
CAGR 10-Years
-21%
Innate Pharma SA
PAR:IPH
Operating Expenses
-€60.5m
CAGR 3-Years
-14%
CAGR 5-Years
6%
CAGR 10-Years
-28%
Genfit SA
NASDAQ:GNFT
Operating Expenses
-€62.7m
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
-15%
Eurobio Scientific SA
PAR:ALERS
Operating Expenses
-€46.7m
CAGR 3-Years
-17%
CAGR 5-Years
-19%
CAGR 10-Years
-8%

See Also

What is Maat Pharma SA's Operating Expenses?
Operating Expenses
-21.6m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Operating Expenses amounts to -21.6m EUR.

What is Maat Pharma SA's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-37%

Over the last year, the Operating Expenses growth was -47%. The average annual Operating Expenses growth rates for Maat Pharma SA have been -60% over the past three years , -37% over the past five years .

Back to Top